Clinical trial
A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
NCT00382135 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00382135 |
|---|---|
| Title | A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg |
| Official title | An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | tadalafil, placebo |
| Enrollment | 282 |
| Start date | Nov 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Sep 28, 2006 |
| Last update posted | Oct 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: